Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Nachury

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Journal of Patient Experience|December 15, 2022
Self-reported Impact of the Early 2020 COVID-19 Crisis on the Healthcare Pathway During and After Lockdown in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Practical SurveyJessica Nasseh, Céline Podevin, Camille Ternynck, et al.
Digestive Diseases and Sciences|October 11, 2019
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's DiseaseClaire Painchart, Séverine Brabant, Nicolas Duveau, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID StudyNicolas Richard, Philippe Seksik, Romain Altwegg, et al.
Patient Preference and Adherence|December 20, 2014
Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©))Hélène Gilet, Benoit Arnould, Fatoumata Fofana, et al.
Inflammatory Bowel Diseases|August 25, 2017
Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to InfliximabLoic Guerbau, Romain Gerard, Nicolas Duveau, et al.
Journal of Crohn'S & Colitis|September 1, 2016
Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease RecurrenceMichael Collins, Hélène Sarter, Corinne Gower-Rousseau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2018
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative ColitisGauthier Pellet, Carmen Stefanescu, Franck Carbonnel, et al.
Journal of Clinical Medicine|December 28, 2019
Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM)Monique Capron, Laurent Béghin, Céline Leclercq, et al.
Gastroenterology|August 14, 2012
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's diseasePierre Desreumaux, Arnaud Foussat, Matthieu Allez, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Journal of Patient Experience|December 15, 2022
Self-reported Impact of the Early 2020 COVID-19 Crisis on the Healthcare Pathway During and After Lockdown in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Practical SurveyJessica Nasseh, Céline Podevin, Camille Ternynck, et al.
Digestive Diseases and Sciences|October 11, 2019
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's DiseaseClaire Painchart, Séverine Brabant, Nicolas Duveau, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2026
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID StudyNicolas Richard, Philippe Seksik, Romain Altwegg, et al.
Patient Preference and Adherence|December 20, 2014
Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©))Hélène Gilet, Benoit Arnould, Fatoumata Fofana, et al.
Inflammatory Bowel Diseases|August 25, 2017
Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to InfliximabLoic Guerbau, Romain Gerard, Nicolas Duveau, et al.
Journal of Crohn'S & Colitis|September 1, 2016
Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease RecurrenceMichael Collins, Hélène Sarter, Corinne Gower-Rousseau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2018
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative ColitisGauthier Pellet, Carmen Stefanescu, Franck Carbonnel, et al.
Journal of Clinical Medicine|December 28, 2019
Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM)Monique Capron, Laurent Béghin, Céline Leclercq, et al.
Gastroenterology|August 14, 2012
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's diseasePierre Desreumaux, Arnaud Foussat, Matthieu Allez, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Pageof 10